Revenue
1.7 million USD
2026 Q2 · USD
Exact inputs and evidence
- Revenue: 1704000 USD Source
Annual consolidated revenue for 2025: about USD 4.089M, using the latest reported figures. The previous period, 2024, was about USD 308K.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
Window: transactions dated on or after 2025-11-17.
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
1.7 million USD
2026 Q2 · USD
-2,590.43%
2026 Q2 · %
-35.3 million USD
2026 Q2 · USD
-35.3 million USD
2026 Q2 · USD
168800000 USD
369214760 shares
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-08-11.
Financial data available through: 2025-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 308,000
–
Current period
USD 4.09 million
–
4089000 − 308000 = 3781000 USD
308000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source4089000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 149.27 million
–
Current period
−USD 660.05 million
–
-660047000 − -149269000 = -510778000 USD
-149269000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-660047000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 82.44 million
–
Current period
−USD 102.68 million
–
-102675000 − -82437000 = -20238000 USD
-82437000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-102675000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 6,000
–
Current period
USD 901,000
–
901000 − 6000 = 895000 USD
6000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source901000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2024 2024-01-01 – 2024-12-31 | 308000 | 102999000 Derived | -102691000 | 46578000 Derived | -149269000 | -82443000 Derived | Source
|
| 2025 2025-01-01 – 2025-12-31 | 4089000 | 648150000 Derived | -644061000 | 15986000 Derived | -660047000 | -103576000 Derived | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2024 | Revenue | 308000 |
|
| 2025 | Revenue | 4089000 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2024 | Year over year | No prior comparable period |
|
| 2025 | Year over year | 1,227.6% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2024 | Operating margin | -33,341.2% |
|
| 2025 | Operating margin | -15,751.1% |
|
| 2024 | Net margin | -48,464% |
|
| 2025 | Net margin | -16,142% |
|
| 2024 | Free cash flow margin | -26,767.2% |
|
| 2025 | Free cash flow margin | -2,533% |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2024 | Operating cash flow | -82437000 |
|
| 2025 | Operating cash flow | -102675000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2024 | Free cash flow | -82443000 |
|
| 2025 | Free cash flow | -103576000 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2024 | Liabilities / assets | 26.9% |
|
| 2025 | Liabilities / assets | 24.2% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2024 | Current assets / current liabilities | 3.21× |
|
| 2025 | Current assets / current liabilities | 11.74× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2024 2024-01-01 – 2024-12-31 | −USD 149.27 million Exact valueExact value: -149269000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 82.44 million Exact valueExact value: -82437000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 6,000 Exact valueExact value: 6000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 82.44 million Calculation and evidence-82437000 − 6000 USD Exact free cash flow: -82443000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2025-01-01 – 2025-12-31 | −USD 660.05 million Exact valueExact value: -660047000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 102.68 million Exact valueExact value: -102675000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 901,000 Exact valueExact value: 901000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 103.58 million Calculation and evidence-102675000 − 901000 USD Exact free cash flow: -103576000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
7 filings · 415 latest values · 415 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0002081043, 2081043, ATAI, edgar:2081043
Also known as ATAI LIFE SCIENCES LUXEMBOURG S.A., ATAIBECKLEY INC., AtaiBeckley Inc., atai Life Sciences Luxembourg S.A.